MyFinsight
Home
Blog
About
Prepaid expenses and
other current assets
$1,752,695
(-6.02%↓ Y/Y)
Cash and cash
equivalents
$676,704
(-69.40%↓ Y/Y)
Unbilled receivable
$416,811
(-65.41%↓ Y/Y)
Total current assets
$2,846,210
(-46.11%↓ Y/Y)
Property and equipment,
net
$111,063
Accumulated deficit
-$145,847,123
(-9.48%↓ Y/Y)
Total assets
$2,957,273
(-46.95%↓ Y/Y)
Total ensysce
biosciences, inc....
-$781,697
(-123.07%↓ Y/Y)
Noncontrolling interests in
stockholders equity...
-$329,136
(-0.15%↓ Y/Y)
Additional paid-in capital
$145,063,802
(6.19%↑ Y/Y)
Common stock, 0.0001
par value,...
$1,624
(573.86%↑ Y/Y)
Total liabilities and
stockholders equity...
$2,957,273
(-46.95%↓ Y/Y)
Total stockholders
equity (deficit)
-$1,110,833
(-136.30%↓ Y/Y)
Total liabilities
$4,068,106
(61.82%↑ Y/Y)
Total current
liabilities
$4,068,106
(61.88%↑ Y/Y)
Accounts payable
$1,977,629
(89.64%↑ Y/Y)
Accrued expenses and
other liabilities
$1,893,635
(81.10%↑ Y/Y)
Notes payable and
accrued interest
$196,842
(-53.63%↓ Y/Y)
Back
Back
Balance Sheet
Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. (ENSC)
source: myfinsight.com